vs
HEALTHEQUITY, INC.（HQY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是HEALTHEQUITY, INC.的1.9倍（$622.0M vs $322.2M），Royalty Pharma plc净利率更高（34.4% vs 16.0%，领先18.4%），HEALTHEQUITY, INC.同比增速更快（7.2% vs 4.8%），过去两年HEALTHEQUITY, INC.的营收复合增速更高（10.8% vs 4.6%）
HealthEquity, Inc.是美国一家金融科技及商业服务企业，拥有美国国税局授予的非银行类健康储蓄受托人资质，无论用户资金存入哪家金融机构，该公司均可作为对应健康储蓄账户的托管方，提供专业账户管理服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HQY vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$322.2M
营收增速更快
HQY
高出2.5%
4.8%
净利率更高
RPRX
高出18.4%
16.0%
两年增速更快
HQY
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $322.2M | $622.0M |
| 净利润 | $51.7M | $214.2M |
| 毛利率 | 70.8% | — |
| 营业利润率 | 24.4% | 62.4% |
| 净利率 | 16.0% | 34.4% |
| 营收同比 | 7.2% | 4.8% |
| 净利润同比 | 806.4% | 2.9% |
| 每股收益（稀释后） | $0.59 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HQYRPRX
| Q4 25 | $322.2M | $622.0M | ||
| Q3 25 | $325.8M | $609.3M | ||
| Q2 25 | $330.8M | $578.7M | ||
| Q1 25 | $311.8M | $568.2M | ||
| Q4 24 | $300.4M | $593.6M | ||
| Q3 24 | $299.9M | $564.7M | ||
| Q2 24 | $287.6M | $537.3M | ||
| Q1 24 | $262.4M | $568.0M |
净利润HQYRPRX
| Q4 25 | $51.7M | $214.2M | ||
| Q3 25 | $59.9M | $288.2M | ||
| Q2 25 | $53.9M | $30.2M | ||
| Q1 25 | $26.4M | $238.3M | ||
| Q4 24 | $5.7M | $208.2M | ||
| Q3 24 | $35.8M | $544.0M | ||
| Q2 24 | $28.8M | $102.0M | ||
| Q1 24 | $26.4M | $4.8M |
毛利率HQYRPRX
| Q4 25 | 70.8% | — | ||
| Q3 25 | 71.4% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 60.6% | — | ||
| Q4 24 | 65.6% | — | ||
| Q3 24 | 68.0% | — | ||
| Q2 24 | 65.1% | — | ||
| Q1 24 | 63.1% | — |
营业利润率HQYRPRX
| Q4 25 | 24.4% | 62.4% | ||
| Q3 25 | 27.5% | 70.1% | ||
| Q2 25 | 25.1% | 36.3% | ||
| Q1 25 | 13.5% | 94.0% | ||
| Q4 24 | 6.5% | 60.9% | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 14.5% | 50.2% | ||
| Q1 24 | 14.8% | -13.0% |
净利率HQYRPRX
| Q4 25 | 16.0% | 34.4% | ||
| Q3 25 | 18.4% | 47.3% | ||
| Q2 25 | 16.3% | 5.2% | ||
| Q1 25 | 8.5% | 41.9% | ||
| Q4 24 | 1.9% | 35.1% | ||
| Q3 24 | 11.9% | 96.3% | ||
| Q2 24 | 10.0% | 19.0% | ||
| Q1 24 | 10.0% | 0.8% |
每股收益（稀释后）HQYRPRX
| Q4 25 | $0.59 | $0.49 | ||
| Q3 25 | $0.68 | $0.67 | ||
| Q2 25 | $0.61 | $0.07 | ||
| Q1 25 | $0.30 | $0.55 | ||
| Q4 24 | $0.06 | $0.46 | ||
| Q3 24 | $0.40 | $1.21 | ||
| Q2 24 | $0.33 | $0.23 | ||
| Q1 24 | $0.30 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $309.3M | $618.7M |
| 总债务越低越好 | $982.1M | $9.0B |
| 股东权益账面价值 | $2.1B | $9.7B |
| 总资产 | $3.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.46× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HQYRPRX
| Q4 25 | $309.3M | $618.7M | ||
| Q3 25 | $304.5M | $938.9M | ||
| Q2 25 | $287.9M | $631.9M | ||
| Q1 25 | $295.9M | $1.1B | ||
| Q4 24 | $322.2M | $929.0M | ||
| Q3 24 | $326.9M | $950.1M | ||
| Q2 24 | $251.2M | $1.8B | ||
| Q1 24 | $404.0M | $843.0M |
总债务HQYRPRX
| Q4 25 | $982.1M | $9.0B | ||
| Q3 25 | $1.0B | $8.9B | ||
| Q2 25 | $1.1B | $8.0B | ||
| Q1 25 | $1.1B | $7.6B | ||
| Q4 24 | $1.1B | $7.6B | ||
| Q3 24 | $1.1B | $7.6B | ||
| Q2 24 | $925.7M | $7.6B | ||
| Q1 24 | $875.0M | $6.1B |
股东权益HQYRPRX
| Q4 25 | $2.1B | $9.7B | ||
| Q3 25 | $2.1B | $9.6B | ||
| Q2 25 | $2.1B | $9.5B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.1B | $10.3B | ||
| Q3 24 | $2.2B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产HQYRPRX
| Q4 25 | $3.4B | $19.6B | ||
| Q3 25 | $3.4B | $19.3B | ||
| Q2 25 | $3.4B | $18.3B | ||
| Q1 25 | $3.4B | $17.6B | ||
| Q4 24 | $3.5B | $18.2B | ||
| Q3 24 | $3.5B | $18.0B | ||
| Q2 24 | $3.2B | $17.7B | ||
| Q1 24 | $3.2B | $16.1B |
负债/权益比HQYRPRX
| Q4 25 | 0.46× | 0.92× | ||
| Q3 25 | 0.47× | 0.93× | ||
| Q2 25 | 0.50× | 0.84× | ||
| Q1 25 | 0.50× | 0.78× | ||
| Q4 24 | 0.51× | 0.74× | ||
| Q3 24 | 0.51× | 0.74× | ||
| Q2 24 | 0.44× | 0.78× | ||
| Q1 24 | 0.43× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $138.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $137.8M | — |
| 自由现金流率自由现金流/营收 | 42.8% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | 2.68× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $413.0M | — |
8季度趋势，按日历期对齐
经营现金流HQYRPRX
| Q4 25 | $138.6M | $827.1M | ||
| Q3 25 | $135.9M | $702.6M | ||
| Q2 25 | $64.7M | $364.0M | ||
| Q1 25 | $75.7M | $596.1M | ||
| Q4 24 | $90.5M | $742.5M | ||
| Q3 24 | $108.1M | $703.6M | ||
| Q2 24 | $65.4M | $658.2M | ||
| Q1 24 | $77.1M | $664.6M |
自由现金流HQYRPRX
| Q4 25 | $137.8M | — | ||
| Q3 25 | $135.1M | — | ||
| Q2 25 | $64.7M | — | ||
| Q1 25 | $75.4M | — | ||
| Q4 24 | $90.3M | — | ||
| Q3 24 | $107.4M | — | ||
| Q2 24 | $64.7M | — | ||
| Q1 24 | $76.5M | — |
自由现金流率HQYRPRX
| Q4 25 | 42.8% | — | ||
| Q3 25 | 41.5% | — | ||
| Q2 25 | 19.5% | — | ||
| Q1 25 | 24.2% | — | ||
| Q4 24 | 30.0% | — | ||
| Q3 24 | 35.8% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 29.2% | — |
资本支出强度HQYRPRX
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.2% | — |
现金转化率HQYRPRX
| Q4 25 | 2.68× | 3.86× | ||
| Q3 25 | 2.27× | 2.44× | ||
| Q2 25 | 1.20× | 12.06× | ||
| Q1 25 | 2.87× | 2.50× | ||
| Q4 24 | 15.88× | 3.57× | ||
| Q3 24 | 3.02× | 1.29× | ||
| Q2 24 | 2.27× | 6.45× | ||
| Q1 24 | 2.92× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HQY
| Financial Service Other | $159.1M | 49% |
| Services | $120.3M | 37% |
| Credit And Debit Card | $42.8M | 13% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
